← Back to Nuqta Atlas
Editorially curated · ae-abu-dhabi-biobank
Abu Dhabi Biobank
Integrated biobank linking biological samples with genomic, clinical, and lifestyle information for early detection, personalized care, research, and cell-therapy development.
01 / Project overview
What the record establishes.
- Geographic scope
- Abu Dhabi, with national research relevance
- Project type
- population and clinical biobank
- Research domain
- biobanking, genomics, regenerative medicine, and precision health
- Years
- 2024–
- Lifecycle status
- operational
- Status basis
- DoH inaugurated the integrated biobank on 3 April 2026; M42 reports more than 900,000 samples stored.
- Status evidence date
- 2026-04-03
- Scale
- Designed for more than 100,000 cord-blood units and up to five million biosamples; M42 reports over 900,000 stored samples.
02 / Organizations and population
Who and what the project connects.
- Lead organizations
- Department of Health - Abu Dhabi · M42
- Partner organizations
- Abu Dhabi Stem Cells Center
- Organism / population
- UAE residents and patients; includes cord-blood donors
03 / Data and access
What exists and how it can be reached.
Data types
- cord blood
- blood and tissue biospecimens
- genomic data
- clinical data
- lifestyle data
Data access
Governed institutional access; no open participant-level data release identified.
Identifiers
No public accession or identifier is listed for this record.
04 / Evidence and provenance
Why the record is included.
Inclusion basis
Nationally important operating biobank with large stated capacity and explicit genomic linkage.
Editorial note
The program was announced before formal inauguration; 2024 is treated as program start and 2026 as operational launch.
Sources
- primary record source Verified 2026-08-15
- additional record source Verified 2026-08-15
- additional record source Verified 2026-08-15
Release v0.2.0